A Selective Neurokinin-1 Receptor Antagonist in Chronic PTSD: A Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Trial

European Neuropsychopharmacology - Netherlands
doi 10.1016/j.euroneuro.2010.11.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Neprilysin Inhibition for Pulmonary Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Trial

British Journal of Pharmacology
Pharmacology
2019English

Fluoxetine for Depression in Diabetes: A Randomized Double-Blind Placebo-Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2000English

A Randomized, Placebo-Controlled, Double-Blind Trial of Sertraline for Postpartum Depression

Psychopharmacology
Pharmacology
2013English

OP0208 a Proof-Of-Concept Double-Blind Randomised Placebo-Controlled Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease

2018English

A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome

Gastroenterology
HepatologyGastroenterology
2008English

Anastrozole in Pulmonary Arterial Hypertension (AIPH): A Randomized, Double-Blind Placebo-Controlled Trial

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2016English

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Neurology
Neurology
2015English

A Randomized Double-Blind Placebo-Controlled Trial of Probiotics in Post-Surgical Colorectal Cancer

BMC Gastroenterology
MedicineGastroenterology
2019English

A Randomized Double-Blind Placebo Controlled Trial of Oral Acyclovir in Renal Allograft Recipients

Canadian Journal of Infectious Diseases
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy